<unk> , sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis. The most common side effects include respiratory tract infections, headache, and urinary tract infections.<unk>  is a neonatal Fc receptor blocker and is a new class of medication. It is an antibody fragment that binds to the neonatal Fc receptor (FcRn), preventing FcRn from recycling immunoglobulin G (IgG) back into the blood. The medication causes a reduction in overall levels of IgG, including the abnormal acetylcholine receptor (AChR) antibodies that are present in myasthenia gravis. It was approved for medical use in the United States in December 2021.
Efgartigimod alfa
Crofelemer
Damoctocog alfa pegol
Asfotase alfa
Tisagenlecleucel
Velmanase alfa
Clinatec
Rubitecan